missing translation for 'onlineSavingsMsg'
Learn More
Learn More
PF 04449613, >98%, Tocris Bioscience™
Click to view available options
Quantity:
10 mg
Description
PF 04449613 is a potent PDE9 inhibitor (IC50 = 22 nM). Also exhibits a high affinity for cGMP (Km ∼170 nM). PF 04449613 reduces body fat in mice with diet-induced obesity, stimulating mitochondrial activity in brown and white fat, and improving cardiometabolic syndrome symptoms. Brain penetrant.
Specifications
Specifications
CAS | 1236858-52-8 |
Molecular Formula | C21H25N5O3 |
Linear Formula | C21H25N5O3 |
Quantity | 10 mg |
Synonym | d04jpg, pde 9 inhibitor alzheimer's disease, pde 9 inhibitor alzheimer's disease , pfizer, phosphodiesterase 9 inhibitor alzheimer's disease , pfizer, 1,5-dihydro-6-1r-1-3-phenoxy-1-azetidinyl ethyl-1-tetrahydro-2h-pyran-4-yl-4h-pyrazolo 3,4-d pyrimidin-4-one |
Solubility Information | Soluble to 100mM in DMSO and to 10mM in 1eq. HCl with gentle warming |
InChI Key | WEDCMPMDOVEMSV-CQSZACIVSA-N |
SMILES | CC(C1=NC(=O)C2=CNN(C2=N1)C3CCOCC3)N4CC(C4)OC5=CC=CC=C5 |
IUPAC Name | 1-(oxan-4-yl)-6-[(1R)-1-(3-phenoxyazetidin-1-yl)ethyl]-2H-pyrazolo[3,4-d]pyrimidin-4-one |
Molecular Weight (g/mol) | 395.463 |
Show More |
missing translation for 'provideContentCorrection'
missing translation for 'productTitle'